155 related articles for article (PubMed ID: 35364643)
1. Identification of a novel immune-related lncRNA signature to predict prognostic outcome and therapeutic efficacy of LGG.
Wu D; Wang X; Xue Y; Sun C; Zhang M
J Integr Neurosci; 2022 Mar; 21(2):55. PubMed ID: 35364643
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
4. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer.
Xu M; Li Q; Zhang J; Xie H
Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
[TBL] [Abstract][Full Text] [Related]
5. Foreboding lncRNA markers of low-grade gliomas dependent on metabolism.
Lu Z; Feng Y
Medicine (Baltimore); 2022 Nov; 101(44):e31302. PubMed ID: 36343057
[TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic immune-related lncRNAs in pancreatic cancer.
Ma Y; He X; Di Y; Liu S; Zhan Q; Bai Z; Qiu T; Corpe C; Wang J
Front Immunol; 2022; 13():1005695. PubMed ID: 36420274
[TBL] [Abstract][Full Text] [Related]
7. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
[TBL] [Abstract][Full Text] [Related]
8. Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.
Qi X; Chen G; Chen Z; Li J; Chen W; Lin J; Lin L
Int J Gen Med; 2021; 14():4279-4289. PubMed ID: 34421308
[TBL] [Abstract][Full Text] [Related]
9. Construction of immune-related lncRNA signature to predict aggressiveness, immune landscape, and drug resistance of colon cancer.
Xue Y; Ning B; Liu H; Jia B
BMC Gastroenterol; 2022 Mar; 22(1):127. PubMed ID: 35300596
[TBL] [Abstract][Full Text] [Related]
10. Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer.
Liu S; Peng X; Wu X; Bu F; Yu Z; Zhu J; Luo C; Zhang W; Liu J; Huang J
World J Surg Oncol; 2022 Mar; 20(1):71. PubMed ID: 35249533
[TBL] [Abstract][Full Text] [Related]
11. Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma.
Wang Y; Zhang X; Dai X; He D
Expert Rev Anticancer Ther; 2021 Oct; 21(10):1161-1170. PubMed ID: 34319826
[No Abstract] [Full Text] [Related]
12. Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma.
Lin Z; Pang K; Li H; Zhang X; Wan J; Zheng T; Liu T; Peng W
Front Cell Dev Biol; 2021; 9():709241. PubMed ID: 34631703
[No Abstract] [Full Text] [Related]
13. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
Hu X; Wu L; Liu B; Chen K
Front Immunol; 2021; 12():651056. PubMed ID: 34122409
[TBL] [Abstract][Full Text] [Related]
14. Signature involved in immune-related lncRNA pairs for predicting the immune landscape of cervical cancer.
Liu X; Wang Z; Wang L; Wang Y; Wang Y; Yang S; Zhang Y
Int J Biol Markers; 2022 Jun; 37(2):191-199. PubMed ID: 35435763
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.
Xu S; Tang L; Liu Z; Luo C; Cheng Q
Front Immunol; 2021; 12():731048. PubMed ID: 34659218
[TBL] [Abstract][Full Text] [Related]
16. An innovative prognostic model based on autophagy-related long noncoding RNA signature for low-grade glioma.
Maimaiti A; Tuerhong M; Wang Y; Aisha M; Jiang L; Wang X; Mahemuti Y; Aili Y; Feng Z; Kasimu M
Mol Cell Biochem; 2022 May; 477(5):1417-1438. PubMed ID: 35152365
[TBL] [Abstract][Full Text] [Related]
17. Immune-Related LncRNAs as Prognostic Factors for Pediatric Rhabdoid Tumor of the Kidney.
Hong Y; Que Y; Hu Y; Shi BY; Zhu J; Wang J; Huang JT; Sun FF; Zhang L; Zhou XK; Lu SY; Zhang YZ
Dis Markers; 2022; 2022():4752184. PubMed ID: 35756490
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
19. A robust immune-related lncRNA signature for the prognosis of human colorectal cancer.
Zhu G; Pei L; Yang F; Zhang C
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35506372
[TBL] [Abstract][Full Text] [Related]
20. Using Immune-Related Long Non-coding Ribonucleic Acids to Develop a Novel Prognosis Signature and Predict the Immune Landscape of Colon Cancer.
Wang X; Chen K; Wang Z; Xu Y; Dai L; Bai T; Chen B; Yang W; Chen W
Front Cell Dev Biol; 2021; 9():750709. PubMed ID: 34660608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
